INTRODUCTION
Visna is an inflammatory and demyelinating disease of the central nervous system of sheep characterized clinically by paralysis. The disease has a prolonged incubation period of months to years, an insidious onset and a subacute progression to death (Sigurdsson et al. I957) . The aetiological agent of Visna is an exogenous retrovirus which replicates by means of a proviral DNA intermediate (Haase & Varmus, I973) . The virus replicates in sheep cell cultures causing acute cytopathic effects (c.p.e.). In contrast, virus replication is slow in sheep. This limitation of replication in vivo could not be overcome by infection of foetal lambs or infection of lambs immunosuppressed by foetal thymectomy or treatment with antilymphocyte serum (Nathanson et al. I976; Narayan et al. I977b) .
Inoculated sheep are persistently infected, although only minimal quantities of cell-free virus can be recovered from tissues during the incubation period or clinical disease. However, virus can be recovered throughout the period of infection by co-cultivation of peripheral blood Ieukocytes (PBL) with cell cultures or by explant cultivation of brain, lung and lymphatic tissues. These cell outgrowths promptly produce virus and develop c.p.e. (Narayan et al. I974; Narayan et al. I977b ) .
Despite the lack of exponential virus growth in vivo (or clinical signs of disease) sheep develop lesions of acute encephalitis (Petursson et al. I976 ) and a prompt but transient virus-specific cell-mediated immune response during the first month after inoculation. During the following weeks inflammatory brain lesions become chronic and the animals develop virus neutralizing antibody (Griffin et al. I978 a, b) . Other studies have shown that, at the time of clinical disease, months or years later, animals have extensive acute and chronic lesions in the brain and spinal cold (Sigurdsson et al. I962) .
The persistence of Visna virus in immune sheep can partially be explained by the sequestration of proviral DNA, which has been demonstrated in nuclei of brain cells by in situ hybridization (Haase et al. I977) . Recurrent inflammatory response leading to slow progression of clinical disease may be dependent on evolution of virulent mutants of the virus during the long infection.
In a previous study we showed that Visna viruses isolated from leukocytes of long term infected sheep were antigenically distinct from the virus used in the original inoculum (Narayan et al. I977a ) . In three of the four sheep studied, the neutralizing antibody was directed exclusively against the inoculum virus, suggesting that the parental virus in the inoculum had mutated and neutralizing antibody had not been stimulated by the mutant viruses. In this report we present evidence for continuous mutation of the virus in the infected animal and describe the biological properties of the mutant viruses and the host response to them.
METHODS
Cell cultures. A cell strain (SCP) derived from explants of choroid plexus of a newborn lamb was used throughout the study. The method of propagation of these cells was described previously (Narayan et al. t977b ) .
Virus and sheep. Two out of four Hampshire sheep (nos. I and 4) previously inoculated intracerebrally with Visna virus strain i5i 4 (Narayan et al. I977a) were studied longitudinally. In addition, two adult Border Leicester sheep (nos. 772, 773) were inoculated with the same strain of virus and three adult Hampshire sheep were inoculated with mutant viruses, tWO (nos. II and I3) with virus strain LVI-I recovered from sheep no. I, and one (no. I2) with strain L¥4-I recovered from sheep no. 4. These inoculations are summarized in Table I .
Virus neutralization tests were performed in a quantal manner by inoculation of SCP cultures in microtitre plates with equal mixtures of doubling dilutions of heated (50 °C for 3 ° rain) sera and Ioo TCDs0 of viIus. Serum-virus mixtures were incubated in a shaking water bath at 37 °C for 30 min prior to the inoculation of four wells with each dilution. Neutralization titres were calculated according to the method of Karber.
Plaquing technique. Confluent monolayer cultures of SCP cells in 60 mm plastic Petri dishes (Costar) were rinsed with minimum essential medium (MEM; GIBCO) and then incubated with 0.2 ml of tenfold dilutions of virus diluted in MEM. Plates were incubated for I h and the inoculum removed with an excess of MEM. The cells were then overlaid with 6 ml of equal mixtures of 2 x MEM + 2 % lamb serum (GIBCO) and ~ % agarose (Marine Colloids). Four to 6 days later a second overlay was applied and on day 14 a third overlay consisting of 3 ml of agarose medium plus 5 % of a I : 20oo suspension of neutral red was applied. Plaques were visualized 24 h later and 'picked' by aspiration of cells in the plaque into a Pasteur pipette followed by resuspension in 2 ml of MEM o/ +2/o lamb serum.
Virus recovery from PBL of infected sheep. Thirty to 50 ml of peripheral blood was Hampshire Io 8 LV4-I:~ * All tbe animals were anaesthetized with halothane and virus in 0'5 ml vol. was inoculated into each cerebral hemisphere through pre-drilled holes in the skull.
t Viruses used for inoculation were plaque purified twice before preparation of the inocula. $ Previously referred to as LVIa and LV4a (Narayan et aL t977a) .
collected aseptically in a heparinized syringe and centrifuged at 2ooo g for Io min. Plasma was discarded and the buffy coat was added to a 5o ml solution of 0"84% ammonium chloride to lyse the red blood cells. The suspension was recentrifuged at 2ooo g for Io min and the cell pellet containing only leukocytes was resuspended and centrifuged twice in Ca 2+-and Mg2+-deficient Hanks' balanced salt solution with 2 % Alsever's solution. The final cell pellet was resuspended in Roswell Park Memorial Institute I64o (RPMI) medium plus 5% foetal calf serum (GIBCO) to a concentration of Io 8 cells/ml. Subconfluent monolayers of SCP cells (approx. Io 6 cells) were then inoculated with Io ml of this cell suspension. One week later the medium was changed to MEM + 1% heated lamb serum which was replaced at weekly intervals for 2 to 3 weeks. The cells were subcultured if no c.p.e, developed. In most cases c.p.e, appeared between 2 to 3 weeks after inoculation. The supernatant fluids from cell cultures with advanced c.p.e, were dispensed in vials, and frozen at -7o °C as a stock PBL virus. Samples of each stock virus were assayed for infectivity before use in neutralization tests. Blood for serum was collected at monthly intervals from all sheep and serum samples were stored at -2o °C. A reference serum from a goat which had been hyperimmunized with I514 virus (Narayan et al. I977b ) was used to compare antigenicities of the different viruses. This serum neutralized I514 virus at a dilution of I/I28o, LVI-I at I/8o and LV4-I at 1/32o.
RESULTS

Temporal development of mutants
The previous demonstration of mutant Visna viruses in leukocytes of chronically infected sheep raised the following questions: is antigenic mutation of the virus a continuous process in the face of neutralizing antibody ? Does one antigenic population of virus replace another after development of antibody to the first virus ?
To answer these questions two infected sheep (nos. I and 4) were studied over a period of 3"5 years. Both animals had been inoculated with plaque purified ~514 virus and had produced neutralizing antibody to the virus. Viruses isolated from PBL of these animals 22 months after inoculation were poorly neutralized by the animals' sera. Although LV4-I (from sheep no. 4) was neutralized at a low dilution of serum from the host animal, LVI-I (from sheep no. ~) failed to be neutralized by serum from the host animal (Narayan et al.
Sheep no. I was studied intensively for evidence of continuing mutation of the virus. Multiple viruses were isolated from the PBL and were tested for neutralization using sequentially collected serum samples. LVI-2 was isolated 6 months after the recovery of LVI-I. Approx. I year later, five viruses: LVI-3, LVI-4, LVI-5, LVI-6, LVI-7 were o. NARAYAN, D. E. GRIFFIN AND J. E. CLEMENTS obtained simultaneously. Viruses recovered from this sheep plus parental 1514 virus were tested for neutralization with three sera collected from the sheep at 2, 3 and 3"5 years after inoculation ( Table 2 ). The neutralization patterns suggested that the viruses could be grouped into 3 antigenic strains: (0 I514 virus and LV-2, (z) LVI-3, LVI-4 and LVI-7, (3) LVI-I, LV/-5 and LVx-6. Further batteries of neutralization tests performed with these viruses and sera collected between years 3 and 4 showed that antibody to each strain developed in sequential order ( Fig. 0 . We inferred from this that the two mutant strains of virus may have evolved sequentially. Routine monitoring of PBL from sheep no. 4 yielded two more viruses, LV4-a and LV4-3 during the 3rd year after inoculation of the animals. LV4-2 identified with/5r4 virus and LV4-3 with LV4-/in neutralization tests with serum collected before and after the isolation of these agents (Fig. I) . The identity of LVi-2 and LV4-2 with /514 was confirmed by similar patterns of neutralization with the reference immune goat serum as well as sera from both animals. This confirmed that mutant as well as the parental virus strains could persist in an immune environment and that a newly emerging mutant virus did not completely replace previous strains of virus.
Two further questions arose from these studies: (r) How soon after inoculation could antigenic mutants be detected ? (a) What is the correlation between emergence (detection) of mutants and development of antibody to the parental virus ?
Two Border Leicester sheep, nos. 772 and 773, were inoculated intracerebrally with Io s TCDs0 of I514 virus. These animals developed an acute cell mediated immune response which coincided with the disappearance of small amounts of cell free virus in the cerebrospinal fluid (CSF) during the first two weeks after inoculation. During the following weeks virus could still be isolated from CSF by co-cultivation of CSF cells, but at later periods PBL were the primary source of virus from the animals (Griffin et aL T978a ). Viruses were obtained from the CSF and blood of the two sheep during the first month post-inoculation and from blood at monthly intervals for the next i6 months. Sheep no. 772 developed neutralizing antibody at 3 weeks post-inoculation and no. 773 at 6 weeks. Antibody titres peaked at 1/64o during the first 6 months and reached a plateau between r/8o to//320.
The CSF and PBL viruses were tested for antigenic variation from I5/4 virus using three sera: (a) serum from no. I sheep, I year after inoculation with I514 virus, (b) and (e) one sample each from nos. 772 and 773 after antibody to I514 virus was first detected. Virus I514 was used as a control each time a group of neutralization tests was performed. More than 4o viruses recovered from leukocytes of the two sheep during the first ro months after inoculation were tested; each was neutralized by the same dilution of serum which neutralized I514 virus. At IO months, seven viruses were obtained from PBL of 5o ml of blood of no. 772. Four of the viruses were neutralized by the sheep's own serum at a dilution of 
Antigenic mutation of Visna virus in sheep
Neutralizing antibody response of sheep inoculated with mutant viruses
Since the mutant viruses obtained from sheep injected with I514 virus differed antigenically from I5r 4 virus and among themselves when tested with 'early' antiq514 sera, sheep were injected with these viruses to examine the specificities of antibodies elicited.
Two sheep (nos. II and I3) infected with LVI-I started producing virus neutralizing antibody 2 months post-inoculation. Antibody titres to LVi-I in sera from no. I ~ rose during the following 6 months to I/x6o but those from no. ~3 remained at I/2o. Surprisingly, sera from both animals neutralized I514 virus at higher dilutions than LV~-I. These sera also neutralized LV4-~ at low dilutions. Since the antibody specificities of the two animals' sera were the same, the data were pooled and mean titres shown (Fig. 2) .
A single sheep (no. I2) inoculated with LV4-I produced neutralizing antibody within 2 months with a specificity similar to the sera from nos. I I and I3 in that there were equivalent or slightly higher amounts of antibody to I514 virus. This sheep did not develop antibody to LVI-I (Fig. 3) -Peripheral blood leukocytes from sheep nos. 1 I, 13 and I2 were examined at 9 months after inoculation for evidence of further mutation of the viruses. Only viruses of the parental 0noculum) antigenicity were obtained at that time.
Biological characteristics and genetic stability of mutant viruses
The replicative efficiencies of the two variant strains were initiated to compare with that of parental I514 virus. Three cultures of SCP cells were inoculated at a multiplicity of o.I TCDs0/cell with LVI-t, LV4-I and I514 virus, and supernatant fluids sampled daily for infectivity assays. The three cultures developed maximum c.p.e, between days 6 and 7 and showed similar rates and efficiencies of replication (Fig. 4) .
To determine genetic stability the two mutant viruses were plaque purified three times by plaque transfer to new cells. Stocks prepared from plaques of the third plaque passage were compared to the original stocks obtained by co-cultivation of PBL with SCP cultures. These parental and progeny viruses were neutralized at the same dilutions of serum from 23 viR 4I o. NARAYAN, D. E. GRIFFIN AND J. E. CLEMENTS the hyperimmune goat: LVI-I and progeny at I/8o and LV4-I and progeny at 1/32o. The mutant viruses were therefore antigenically stable after plaque purification. The foregoing plaque purification would have rid the stock of pseudotypes. Fulther tests to determine whether the mutant viruses were heterozygotes of virus I5~4 and LVI-I, and would produce either virus I514 or LVI-I with high frequency were performed by examination of progeny from 3I plaque samples of LVI-I. The goat serum which neutralized I514 virus at a dilution of i/I28O, neutralized the 3t progeny viruses as well as LVI-I at a dilution of I/8O. These results suggest that the variant properties of the mutants are stable and genetically determined. Given the equivalent replicative efficiencies of the viruses, a very high reversion rate would have had to occur to obtain the high antibody titres to parental virus i5i 4 in sheep Ix, I3 and I2.
DISCUSSION
This study showed that in sheep persistently infected with Visna virus, the agent underwent progressive antigenic drift over a period of years in concert with development of neutralizing antibody to pre-existing strains of virus. This constant evolution of stable antigenic mutants appears to be a special adaptation of this virus to its host. Similar antigenic alterations have been observed in the aetiological agents causing recurrent acute diseases of man and animals such as trypanosomiasis (Vickerman, I974) , malaria (Brown, I974) and equine infectious anaemia (Kono et al. I973) . The slow process of mutation and selection observed in vivo can be greatly accelerated in cell cultures since we have recently shown that cell cultures inoculated with a plaque suspension of I514 virus and maintained in medium containing anti-I5~4 antibody produced a stable mutant within 3 weeks (Narayan et al. ~977a ; O. Narayan, unpublished data). The only limitation for progressive mutation in the cell culture system appeared to be the lack of appropriate antibody to the newly evolved mutants for further selection of new mutants. This obstacle was overcome in the animal in which virus can replicate, albeit very slowly, and in which antibody can be stimulated, thus providing the environment for repetitive cycles of virus growth, antibody induction, mutation and selective growth of mutants.
The one way cross-reactions demonstrated between the mutants and the parental strain of Visna virus resemble in some way the cross-reactions seen among other closely related virus groups such as influenza A (Schulman & Kilbourne, I965) and the measles-canine distemper-rinderpest complex (Imagawa, I968 ) . However, in the latter two groups, serum antibody titres are against the homologous virus while for Visna the mutant viruses LVI-I and LV4-I induced higher antibody titres to I5~4 virus. This suggests that parental and mutant viruses have fundamentally the same antigenic composition and that mutation may alter the avidity with which the virus protein necessary for neutralization is bound by neutralizing antibody.
It should be pointed out that only two mutants were examined by inoculation into sheep, but if mutants generally evolve this antigenic relationship to parental virus, such mutations would function to the advantage of the evolving mutant since antibodies to the parental virus cause little neutralization of mutants. This pattern of one way cross reactions would favour a progressive antigenic drift away from the parental strain.
Although the mechanisms of derivation of mutant Visna viruses with respect to the role of antibody is open to speculation, the mutants appear to differ from the parental strain only in antigenicity as detected by neutralization. Their unique antigenicity was stable after multiple subcultures and plaque purifications and their efficiency of replication and virulence for cell cultures were similar to those of the parental strain. Further, when inoculated into sheep, they induced pathological evidence of acute encephalitis (0. Narayan, unpublished data). Thus, the mutant viruses are not only antigenically stable but are also fully virulent. These biological properties of the mutant viruses reinforce our hypothesis for the pathogenesis of the chronic disease, since the sequential replication of each mutant in the central nervous system may be accompanied by new pathological lesions which could cumulatively lead to clinical disease years after inoculation.
Aside from endogenous virus infections, persistent infections are usually thought to result either from defective replication of virus in the immunologically normal host such as subacute sclerosing panencephalitis (Johnson & ter Meulen, 1978) , or normal replication of the virus in immature or immunologically impaired host such as lymphocytic choriomeningitis (Hotchin, 1g71) , rubella (Olson et al. 1968 ) and progressive multifocal leukoencephalopathy (Weiner & Narayan, 1974) . In Visna of sheep, the virus is not defective and the host is not compromised; rather, slowness of disease appears dependent on development of complete virulent mutants and their selection by a competent host immune response.
